Biomerica, Inc (BMRA): Net earnings per share (EPS TTM)

Public company logo of Biomerica, Inc (BMRA)

Biomerica, Inc. (BMRA) market positions are limited to narrow GI diagnostics niches, despite patent protection. The rolling net income per share snapshot demonstrates the current adaptability of the business, where -1.65 reflects the latest metric value. Growth is driven by the expansion of non-invasive tests into pharmacy chains, while resilience is bolstered by the implementation of ESG environmental standards and packaging recycling.

BMRA Biomerica Inc Net earnings per share for the last four quarters (07/04/2022 - 11/17/2026)

Metric breakdowns and analytics for Biomerica Inc (BMRA)

- current quotes and average value forecast:
Basic company analysis:BMRA - Biomerica Inc.
Manufactured products of Biomerica, Inc

For Biomerica, Inc. (BMRA), earnings per share reflects the monetization efficiency of InFoods tests and the reach of pharmacy chains. This indicator is calculated as the ratio of total annual income to the total number of outstanding securities. By analyzing a slice of rolling earnings per share, an investor separates real returns from price volatility. This metric allows for an assessment of capital dilution risk, serving as a key marker of business sustainability.

Competitor analysis

agilent.com - Net earnings per share (EPS TTM)|Net earnings per share for the last four quarters Quest Diagnostics Inc. DGX|ILMN: Net earnings per share (EPS TTM)|EXAS - Net earnings per share for the last four quarters|Earnings per share for the last twelve months revvity.com|Earnings per share for the last twelve months BIO|Net earnings per share (EPS TTM) NNNN|SHC - Net earnings per one share for the last twelve months|Quidel Corporation - Net earnings per share for the last 12 months|Net earnings per share (EPS TTM) OPKO Health Corp. OPK|CDNA - Earnings per share for the last twelve months|Earnings per share for the trailing year MRVI (Maravai LifeSciences)|FLGT: Net earnings per share (EPS TTM)|Earnings per share for the last 12 months LAB|Earnings per share for the last twelve months Cytek Biosciences Inc|Net earnings per share (EPS TTM) OraSure Corp|Net earnings per share for the last 12 months XGN (Exagen Inc)|Net earnings per share (EPS TTM) mdxhealth.com (MDXH)|Net earnings per share (EPS TTM) LUCD (Lucid Diagnostics Inc)|PRE - Net earnings per share for the last 12 months|IMDX: Net earnings per share for the last 12 months|Earnings per share for the trailing year TRIB (trinitybiotech.com)|PRPH (ProPhase Labs, Inc.) - Net earnings per share for the last 12 months|Net earnings per share for the last 12 months Ainos|Earnings per share for the last twelve months Co-Diagnostics Inc|HSCS (Heart Test Laboratories Inc.) - Earnings per share for the last four quarters|Net earnings per share (EPS TTM) CDIO|Net earnings per share for the last four quarters Onconetix Corporation|Net earnings per share (EPS TTM) VRAX (Virax Biolabs Group)|Net earnings per share for the trailing year bluejaydx.com|AWH: Net earnings per share for the last 12 months|Net earnings per share for the last four quarters Accelerate Diagnostics, Inc. AXDX|CNTG (CENTOGENE) - Net earnings per share for the last 12 months|Earnings per share for the last 12 months ENZ|FRES: Net earnings per share for the last four quarters|Earnings per share for the last twelve months GENE|Net earnings per share for the last 12 months ME (23andMe Holding Co)|PMD - Net earnings per one share for the last twelve months